SE518619C2 - Komposition för reglerad frisättning innehållande monokaproin - Google Patents

Komposition för reglerad frisättning innehållande monokaproin

Info

Publication number
SE518619C2
SE518619C2 SE9404289A SE9404289A SE518619C2 SE 518619 C2 SE518619 C2 SE 518619C2 SE 9404289 A SE9404289 A SE 9404289A SE 9404289 A SE9404289 A SE 9404289A SE 518619 C2 SE518619 C2 SE 518619C2
Authority
SE
Sweden
Prior art keywords
composition
composition according
mixture
monocaproin
biologically active
Prior art date
Application number
SE9404289A
Other languages
English (en)
Swedish (sv)
Other versions
SE9404289L (sv
SE9404289D0 (sv
Inventor
Kaare Larsson
Helena Ljusberg-Wahren
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Priority to SE9404289A priority Critical patent/SE518619C2/sv
Publication of SE9404289D0 publication Critical patent/SE9404289D0/xx
Priority to DE69525761T priority patent/DE69525761T2/de
Priority to AT95941306T priority patent/ATE213932T1/de
Priority to EP95941306A priority patent/EP0790822B1/en
Priority to PCT/SE1995/001479 priority patent/WO1996017597A1/en
Priority to AU42768/96A priority patent/AU4276896A/en
Priority to BR9509897A priority patent/BR9509897A/pt
Priority to CA002207218A priority patent/CA2207218C/en
Priority to JP51754296A priority patent/JP3487860B2/ja
Priority to US08/836,103 priority patent/US5906831A/en
Priority to ES95941306T priority patent/ES2170171T3/es
Publication of SE9404289L publication Critical patent/SE9404289L/xx
Priority to FI972415A priority patent/FI972415A/fi
Priority to NO972614A priority patent/NO972614D0/no
Publication of SE518619C2 publication Critical patent/SE518619C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
SE9404289A 1994-09-12 1994-12-09 Komposition för reglerad frisättning innehållande monokaproin SE518619C2 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE9404289A SE518619C2 (sv) 1994-12-09 1994-12-09 Komposition för reglerad frisättning innehållande monokaproin
ES95941306T ES2170171T3 (es) 1994-12-09 1995-12-08 Composicion de liberacion controlada que forma una estructura micelar inversa (l2) o una estructura micelar normal (l1).
BR9509897A BR9509897A (pt) 1994-12-09 1995-12-08 Composição de liberação controlada para um material biologicamente ativo uso da mesma processo para preparação de uma composição de liberação controlada e para administração a mamíferos especialmente ao homem de um material biologicamante ativo e composição para uso como uma composição medicinal nasal
JP51754296A JP3487860B2 (ja) 1994-12-09 1995-12-08 逆ミセル（ｌ２）構造または正常ミセル（ｌ１）構造を形成する制御放出組成物
EP95941306A EP0790822B1 (en) 1994-12-09 1995-12-08 Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure
PCT/SE1995/001479 WO1996017597A1 (en) 1994-12-09 1995-12-08 Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure
AU42768/96A AU4276896A (en) 1994-12-09 1995-12-08 Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure
DE69525761T DE69525761T2 (de) 1994-12-09 1995-12-08 MITTEL MIT GESTEUERTER FREISETZUNG, DIE EINE UMGEKEHRTE MICELLARE (L2) STRUKTUR ODER EINE NORMALE MICELLARE (l1) STRUKTUR BILDEN
CA002207218A CA2207218C (en) 1994-12-09 1995-12-08 Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure
AT95941306T ATE213932T1 (de) 1994-12-09 1995-12-08 Mittel mit gesteuerter freisetzung, die eine umgekehrte micellare (l2) struktur oder eine normale micellare (l1) struktur bilden
US08/836,103 US5906831A (en) 1994-09-12 1995-12-08 Controlled release composition forming a reversed micellar (L2) structure or a normal micellar (L1) structure
NO972614A NO972614D0 (no) 1994-12-09 1997-06-06 Preparat med kontrollert frigivelse som danner en reversert micelle (L2)-struktur eller en normal micelle (L1)-struktur
FI972415A FI972415A (fi) 1994-12-09 1997-06-06 Käänteismiselli-(L2) tai normaalin misellirakenteen (L1) muodostava koostumus, josta vapautuminen on säädeltyä

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9404289A SE518619C2 (sv) 1994-12-09 1994-12-09 Komposition för reglerad frisättning innehållande monokaproin

Publications (3)

Publication Number Publication Date
SE9404289D0 SE9404289D0 (sv) 1994-12-09
SE9404289L SE9404289L (sv) 1996-06-10
SE518619C2 true SE518619C2 (sv) 2002-10-29

Family

ID=20396276

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9404289A SE518619C2 (sv) 1994-09-12 1994-12-09 Komposition för reglerad frisättning innehållande monokaproin

Country Status (13)

Country Link
US (1) US5906831A (no)
EP (1) EP0790822B1 (no)
JP (1) JP3487860B2 (no)
AT (1) ATE213932T1 (no)
AU (1) AU4276896A (no)
BR (1) BR9509897A (no)
CA (1) CA2207218C (no)
DE (1) DE69525761T2 (no)
ES (1) ES2170171T3 (no)
FI (1) FI972415A (no)
NO (1) NO972614D0 (no)
SE (1) SE518619C2 (no)
WO (1) WO1996017597A1 (no)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
EP1463545B3 (en) * 2001-11-08 2008-12-10 Atrium Medical Corporation Intraluminal device with a coating containing a therapeutic agent
JP2005515197A (ja) * 2001-12-03 2005-05-26 ドー バイオファーマ インコーポレイテッド 安定化された逆ミセル組成物およびその使用
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US9592324B2 (en) 2006-11-06 2017-03-14 Atrium Medical Corporation Tissue separating device with reinforced support for anchoring mechanisms
US8001922B2 (en) 2004-09-28 2011-08-23 Atrium Medical Corporation Application of a coating on a medical device
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006036970A2 (en) * 2004-09-28 2006-04-06 Atrium Medical Corporation Method of thickening a coating using a drug
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
EP1819297B1 (en) 2004-09-28 2015-01-14 Atrium Medical Corporation Uv cured gel and method of making
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
EP1933991A4 (en) 2005-10-15 2012-05-02 Atrium Medical Corp HYDROPHOBIC NETWORKED GEL FOR BIOABSORBIBLE MEDICINAL CARRIER COVERS
US7670997B2 (en) * 2006-06-08 2010-03-02 Bausch & Lomb Incorporated Ophthalmic compositions comprising a branched, glycerol monoalkyl compound and a fatty acid monoester
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
WO2009021007A1 (en) 2007-08-06 2009-02-12 Serenity Pharmaceuticals Corporation Methods and devices for desmopressin drug delivery
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
NO2296686T3 (no) * 2008-05-21 2014-07-12
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
EP2593141B1 (en) 2010-07-16 2018-07-04 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
US9744542B2 (en) 2013-07-29 2017-08-29 Apeel Technology, Inc. Agricultural skin grafting
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
CN107709349B (zh) 2015-05-20 2022-01-28 阿比尔技术公司 植物提取物组合物和制备其的方法
EP3349589B1 (en) 2015-09-16 2022-12-14 Apeel Technology, Inc. Method for forming a protective coating by applying fatty acid glyceride compounds to a surface
WO2017100636A1 (en) 2015-12-10 2017-06-15 Apeel Technology, Inc. Plant extract compositions for forming protective coatings
EP3407713A1 (en) 2016-01-26 2018-12-05 Apeel Technology, Inc. Method for preparing and preserving sanitized products
CN110087475B (zh) 2016-11-17 2023-04-11 阿比尔技术公司 由植物提取物形成的组合物及其制备方法
WO2018098501A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
US11641865B2 (en) 2020-03-04 2023-05-09 Apeel Technology, Inc. Compounds and formulations for protective coatings
WO2022094339A1 (en) 2020-10-30 2022-05-05 Apeel Technology, Inc. Compositions and methods of preparation thereof
KR20230101840A (ko) * 2020-11-04 2023-07-06 인올렉스 인베스트먼트 코포레이션 바이오 기반 글리세릴 헵타노에이트 에스테르 조성물, 이를 제조 및 사용하는 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
SE457693B (sv) * 1986-07-01 1989-01-23 Drilletten Ab Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas

Also Published As

Publication number Publication date
US5906831A (en) 1999-05-25
JP3487860B2 (ja) 2004-01-19
FI972415A0 (fi) 1997-06-06
NO972614L (no) 1997-06-06
BR9509897A (pt) 1997-12-30
ATE213932T1 (de) 2002-03-15
DE69525761T2 (de) 2002-10-24
SE9404289L (sv) 1996-06-10
SE9404289D0 (sv) 1994-12-09
DE69525761D1 (de) 2002-04-11
CA2207218C (en) 2002-02-12
EP0790822A1 (en) 1997-08-27
NO972614D0 (no) 1997-06-06
FI972415A (fi) 1997-06-06
CA2207218A1 (en) 1996-06-13
EP0790822B1 (en) 2002-03-06
JPH10510260A (ja) 1998-10-06
ES2170171T3 (es) 2002-08-01
WO1996017597A1 (en) 1996-06-13
AU4276896A (en) 1996-06-26

Similar Documents

Publication Publication Date Title
SE518619C2 (sv) Komposition för reglerad frisättning innehållande monokaproin
EP0580778B1 (en) Convertible microemulsion formulations
Narang et al. Stable drug encapsulation in micelles and microemulsions
Constantinides Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects
Gurram et al. Role of components in the formation of self-microemulsifying drug delivery systems
US5298246A (en) Stable pharmaceutical composition and method for its production
AU2011206629B2 (en) Pharmaceutical compositions for oral administration of insulin peptides
US20040147578A1 (en) Use of lipoaminoacids as absorption promoters in a pharmaceutical composition
US20220202768A1 (en) Dihydromyricetin nanoemulsion formulations and methods for forming them
EP0746331B1 (en) Convertible microemulsion formulations
US6770292B2 (en) Pharmaceutical compositions for oral administration
Tanawade et al. Self-emulsifying drug delivery systems: an overview
Agubata Self-emulsifying formulations: A pharmaceutical review
Kaushik et al. Introduction to Lipid-Based Drug Delivery Systems for Oral Delivery
Agatonovic-Kustrin et al. Strategy for the development of a thermodynamically stable oral microemulsion
US20120252906A1 (en) Bioavailability Enhancement Delivery Composition
Souto et al. Lipid Matrix Nanoparticles in Diabetes
Mishra et al. In-vivo Self Emulsification: Tools for Bioavailability Enhancement

Legal Events

Date Code Title Description
NUG Patent has lapsed